Opening The “Black Box” Of Japanese Medical Device Review – An Interview With Kaye Suzuki
This article was originally published in The Gray Sheet
Executive Summary
Europe, United States, Japan: For medical device companies seeking an international market, this is a well-trod path
You may also be interested in...
Boston Scientific’s Taxus Express2 To Make Long-Awaited Debut In Japan
Boston Scientific expects to launch its Taxus Express2 paclitaxel-eluting stent in Japan in four to six weeks, once the Japanese Ministry of Health, Labor and Welfare establishes reimbursement for the device
Boston Scientific’s Taxus Express2 To Make Long-Awaited Debut In Japan
Boston Scientific expects to launch its Taxus Express2 paclitaxel-eluting stent in Japan in four to six weeks, once the Japanese Ministry of Health, Labor and Welfare establishes reimbursement for the device
East To Meet West On Cardiovascular Clinical Trial Design
FDA and Japanese regulatory authorities will meet in January to discuss a project for establishing "global" cardiovascular device clinical studies capable of satisfying approval requirements in both countries